Rotavirus Serotypes: Classification and Importance in Epidemiology, Immunity, and Vaccine Development

Journal of Health Population and Nutrition

Volumn 18, Issue 1, 2000, Pages 5-14

  Hoshino, Yasutaka ^a   Kapikian, Albert Z ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Immunity; Rotavirus; Serotyping: Epidemiology; Vaccine development

Indexed keywords

EPITOPE; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

CHILD; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; INFANTILE DIARRHEA; ISOLATION AND PURIFICATION; MALE; NEWBORN; PRESCHOOL CHILD; REVIEW; ROTAVIRUS; SEROTYPING; VIRUS INFECTION;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DIARRHEA, INFANTILE; EPITOPES; FEMALE; GENOTYPE; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEROTYPING;

EID: 0034198176     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Advisory Committee on Immunization Practices. RotavinisRotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR 1999;48:1-23.
2. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP et al. editors. Virology. 3d ed. Philadelphia: Lippincott-Raven, 1996;1657-708.
3. 2a. Reoviridae Study Group for ICTV (Merten P, chair). The Reoviridae. 1998:1-119.
4. Estes MK. Rotaviruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP et al., editors. Virology. 3d ed. Philadelphia: Lippincott-Raven, 1996:1625-55.
5. Krishnan T, Sen A, Sinha Choudhury J, Das S, Naik TN, Bhattacharya SK. Emergence of adult diarrhoea rotavirus in Calcutta, India. Lancet 1999;353:380-1.
6. Hoshino Y, Kapikian AZ. Rotavirus antigens. Curr Topics Microbiol Immunol 1994;185:179-221.
7. Greenberg HB, Valdesuso J, van Wyke K, Midthun K, Walsh M, McAuliffe V et al. Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol 1983;47:267-75.
8. Hoshino Y, Sereno MM, Midthun K, Flores J, Kapikian AZ, Chanock RM. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci USA 1985;82:8701-4.
9. Offit PA, Blavat G. Identification of the two rotavirus genes determining neutralization specificities. J Virol 1986;57:376-8.
10. Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J Virol 1988;62:744-8.
11. Matsui SM, Mackow ER, Greenberg HB. Molecular determinant of rotavirus neutralization and protection. Adv Virus Res 1989;36:181-214.
12. Offit PA, Shaw RD, Greenberg HB. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J Virol 1986;58:700-3.
13. Offit PA, Clark HF, Blavat G, Greenberg HB. Reassortant rotaviruses containing structural proteins VP3 and VP7 from different parents induce antibodies protective against each parental serotype. J Virol 1986;60:491-6.
14. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP et al., editors. Virology. 3d ed. Philadelphia: Lippincott-Raven, 1996;1397-445.
15. Hoshino Y, Jones RW, Kapikian AZ. Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain. Arch Virol 1998;143:1233-44.
16. Chen D, Burns JW, Estes MK, Ramig RF. Phenotypes of rotavirus reassortants depend upon the recipient genetic background. P roc Natl Acad Sci USA 1989;86:3743-7.
17. Browning GF, Fitzgerald TA, Chalmers RM, Snodgrass DR. A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23. J Clin Microbiol 1991;29:2043-6.
18. Hoshino Y, Kapikian AZ. Classification of rotavirus VP4 and VP7 serotypes. Arch Virol 1996;12(Suppl):99-111.
19. Akatani K, Ikegami N. Typing of fecal rotavirus specimens by enzyme-linked immunosorbent assay using monoclonal antibodies. Clin Virol 1987;156:618 (Jap).
20. Coulson BS, Unicomb LE, Pitson GA, Bishop RF. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol 1987;25:509-15.
21. Shaw RD, Stoner-Ma DL, Estes MK, Greenberg HB. Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol 1985;22:286-91.
22. Taniguchi K, Urasawa T, Monta Y, Greenberg HB, Urasawa S. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis 1987;155:1159-66.
23. Palombo EA, Bugg HC, Masendycz PJ, Bishop RF. Sequence of the VP7 gene of an atypical human rotavirus: evidence for genetic and antigenic drift. DNA Seq 1997;7:307-11.
24. Green KY, James HD, Jr., Kapikian AZ. Evaluation of three panels of monoclonal antibodies for the identification of human rotavirus VP7 serotypcs by ELISA. Bull World Health Organ 1990;68:601-10.
25. Hasegawa A, Mukoyama A, Akatani K, Ikegami N, Urasawa S, Ushijima H. Serotyping of human rotavirus by enzyme immuno-assay with monoclonal antibodies. Jpn J Med Sci Biol 1993;46:221-6.
26. Contreras JF, Menchaca GE, Padilla-Noriega L, Tamez RS, Greenberg HB, Lopez S et al. Heterogeneity of VP4 neutralization epitopes among serotype PI A human rotavirus strains. Clin Diagn Lab Immunol 1995;2:506-8.
27. Coulson BS. Typing of human rotavirus VP4 by enzyme immunoassay using monoclonal antibodies. J Clin Microbiol 1993;31:1-8.
28. Coulson BS. VP4 and VP7 typing using monoclonal antibodies. Arch Virol 1996;12(Suppl):113-8.
29. Masendycz PJ, Palombo EA, Gorrell PJ, Bishop RF. Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types). J Clin Microbiol 1997;35:3104-8.
30. Padilla-Noriega L, Wemer-Eckert R, Mackow ER, Gorziglia M, Larralde G, Taniguchi K et al. Serologic analysis of human rotavirus scrotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol 1993;31:622-8.
31. Padilla-Noriega L, Mendez-Toss M, Menchaca G, Contreras JF, Romero-Guido P, Puerto, FI et al. Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico. J Clin Microbiol 1998;36:1688-92.
32. Flores J, Sears J, Perez-Schael I, White L, Garcia D, Lanata C, Kapikian AZ. Identification of human rotavirus serotype by hybridization to polymerasechain reaction-generated probes derived from a hyperdivergent region of the gene encoding outer capsid protein VP7. J Virol 1990;64:4021-4.
33. Zheng BJ, Lam WP, Van YK, Lo SKF, Lung ML, Ng MH. Direct identification of serotypes of natural human rotavirus isolates by hybridization using cDNA probes derived from segment 9 of the rotavirus genome. J Clin Microbiol 1989;27:552-7.
34. Das BK, Gentsch JR, Cicirrelo HO, Woods PA, Gupta A, Ramachandran M et al. Characterization of rotavirus strains from new borns in New Delhi, India. J Clin Microbiol 1994;32:1820-2.
35. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30:1365-73.
36. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28:276-82.
37. Nishikawa K, Hoshino Y, Taniguchi K, Green KY, Greenberg HB, Kapikian AZ et al. Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology 1989;171:503-15.
38. Arista S, Vizzi E, Ferraro D, Cascio A, DiStefano R. Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrhea. Arch Virol 1997;142:2065-71.
39. Beards GM, Desselberger U, Flewett TH. Temporal and geographical distributions of human rotavirus serotypes 1983-1988. J Clin Microbiol 1989;27:2827-33.
40. Bern C, Unicomb L, Gentsch JR, Banul N, Yunus M, Sack RB et al. Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol 1992;30:3234-8.
41. Cunliffe NA, Kilgore PE, Bresee JS, Steele AD, Luo N, Hart CA et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 1998;76:525-37.
42. Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, Woods PA, Bresee JS et al. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999;57:308-12.
43. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis 1996;174(Suppl):S30-S36.
44. Gunasena S, Nakagomi O, Isegawa Y, Kaga E, Nakagomi T, Steele AD et al. Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea. J Clin Microbiol 1993;31:2195-7.
45. Kaga E, lizuka M, Nakagomi T, Nakagomi O. The distribution of G (VP7) and P (VP4) serotypes among human rotaviruses recovered from Japanese children with diarrhea. Microbiol Immunol 1994;38:317-20.
46. Masendycz PJ, Unicomb LE, Kirkwood CS, Bishop RF. Rotavirus serotypes causing acute diarrhea in young children in six Australian cities, 1989-1992. J Clin Microbiol 1994;32:2315-7.
47. Mphahlele MJ, Steele AD. Relative frequency of human rotavirus VP4 (P) genotypes recovered over a ten-year period from South African children with diarrhea. J Med Virol 1995;47:1-5.
48. O'Mahony J, Foley B, Morgan S, Morgan JG, Hill C. VP4 and VP7 genotyping of rotavirus samples recovered from infected children in Ireland over a 3-year period. J Clin Microbiol 1999;37:1699-703.
49. O'Ryan M, Mamani N, Avendano LF, Cohen J, Pena A, Villarroel J et al. Molecular epidemiology of human rotaviruses in Santiago, Chile. Pediatr Infect Dis J 1997;16:305-11.
50. Padilla-Noriega L, Arias CF, Lopez S, Puerto F, Snodgrass DR, Taniguchi K et al. Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol 1990;28:1114-9.
51. Qiao H, Nilsson M, Abreu ER, Hedlund K-O, Johansen K, Zaori G et al. Virol diarrhea in children in Beijing, China. J Med Virol 1999;57:390-6.
52. Ramachandran M, Gentsch JR, Parashar UD, Jin S, Woods PA, Holmes JL et al. Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol 1998;36:3223-9.
53. Rasool NBG, Larralde G, Gorziglia MI. Determination of human rotavirus VP4 using serotype-specific cDNA probes. Arch Virol 1993;133:275-82.
54. Santos N, Riepenhoff-Talty M, Clark HF, Offit P, Gouvea V. VP4 genotyping of human rotavirus in the United States. J Clin Microbiol 1994;32:205-8.
55. Silverstein I, Shilman LM, Mendelson E, Shif I. Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children. J Clin Microbiol 1995;33:1421-2.
56. Steele AD, van Niekerk MC, Mphahlele MJ. Geographic distribution of human rotavirus VP4 genotypes and VP7 serotypes in five South African regions. J Clin Microbiol 1995;33:1516-9.
57. Timenetsky MCST, Santos N, Gouvea V. Survey of rotavirus G and P types associated with human gastroenteritis in São Paulo, Brazil, from 1986 to 1992. J Clin Microbiol 1994;32:2622-4.
58. Urasawa S, Urasawa T, Taniguchi K, Wakasugi F, Kobayashi N, Chiba S et al. Survey of human rotavirus serotypes in different locales in Japan by enzyme-linked immunosorbent assay with monoclonal antibodies. J Infect Dis 1989;160:44-51.
59. Ushijima H, Gentsch J, Yoshikura H, Glass R. P and G typing by PCR of rotaviruses isolated in Japan. Chin J Virol 1994;10:316-320 (Chin).
60. Ushijima H, Mukoyama A, Hasegawa A, Nishimura S, Komshi K, Bosu K. Serotyping of human rotaviruses in the Tokyo area (1990-1993) by enzyme immunoassay with monoclonal antibodies and by reverse transcription and polymerase chain reaction amplification. J Med Virol 1994;4:162-5.
61. Wu H, Taniguchi K, Wakasugi F, Ukae S, Chiba S, Ohseto M et al. Survey on the distribution of the gene 4 alleles of human rotaviruses by polymerase chain reaction. Epidemiol Infect 1994;112:615-22.
62. Sukumaran M, Gowda K, Maiya PP, Srinivas TP, Kumar MS, Aijas S et al. Exclusive asymptomatic neonatal infections by human rotavirus strains having subgroup I specificity and 'long' RNA electropherotype. Arch Virol 1992;126:239-51.
63. Das M, Dunn SJ, Woode ON, Greenberg HB, Rao CD. Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (1321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology 1993;194:374-9.
64. Das BK, Gentsch JR, Hoshino Y, Ishida S-I, Nakagomi O, Bhan MK et al. Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. Virology 1993;197:99-107.
65. Dunn SJ, Greenberg HB, Ward RL, Nakagomi O, Burns JW, Vo PT et al. Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol 1993;31:165-9.
66. Ramachandran M, Das BK, Vij A, Kumar R, Bhambal SS, Kesari N et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol 1996;34:436-9.
67. Gouvea V, de Castro L, Timenetsky MCST, Greenberg HB, Santos N. Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol 1994;32:1408-9.
68. Alfieri AA, Leite JPG, Nakagomi O, Glass RI, Gentsch JR. Characterization of human rotavirus genotype P[8]G5 from Brazil by probe-hybridization and sequence. Arch Virol 1996;141:2353-64.
69. Wyatt RG, Greenberg HB, James WD, Jr., Pittman AL, Kalica AR, Flores J et al. Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun 1982;37:110-5.
70. Hoshino Y, Torres A, Aves TM, Flores G, Lin J-H, Sereno MM, Kapikian AZ. Neutralizing antibody response of gnotobiotic piglets after fetal infection and neonatal challenge with human rotavirus strains. J Infect Dis 1987;156:1038-40.
71. Snodgrass DR, Fitzgerald TA, Campbell I, Browning GF, Scott FMM, Hoshino Y et al. Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naïve and experienced animals. J Clin Microbiol 1991;29:2668-72.
72. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis 1990;161:667-79.
73. Wyatt RG, Kapikian AZ, Mebus CA. Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus. J Clin Microbiol 1983;18:505-8.
74. Gaul SK, Simpson TF, Woode GN, Fulton RW. Antigenic relationships among some animal rotaviruses: virus neutralization in vitro and cross-protection in piglets. J Clin Microbiol 1982;16:495-503.
75. Saif LJ, Redman DR, Smith KL, Theil KW. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or non-immunized cows. Infect Immun 1983;41:1118-31.
76. Snodgrass DR, Wells PW. Rotavirus infection in lambs: studies on passive protection. Arch Virol 1976;52:201-5.
77. Snodgrass DR, Ojeh CK, Campbell I, Herring AJ. Bovine rotavirus serotypes and their significance for immunization. J Clin Microbiol 1984;20:342-6.
78. Woode GN, Kelso NE, Simpson TF, Gaul SK, Evans LE, Babiuk L. Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves. J Clin Microbiol 1983;18:358-64.
79. Offit PA, Clark HF. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J Infect Dis 1985;152:1152-8.
80. Bridger JC, Oldham G. Avirulent rotavirus infections potect calves from disease with and without inducing gh levels of neutralizing antibody. J Gen Virol 1987;68:2311-7.
81. Ward RL, McNeal MM, Sheridan JF. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 1992;188:57-66.
82. Woode GN, Zheng SL, Rosen BI, Knight N, Kelso Gourley NE, Ramig RF. Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. J Clin Microbiol 1987;25:1052-8.
83. Bohl EH, Theil KW, Saif LJ. Isolation and serolyping. of porcine rotaviruses and antigenic comparison with other rotaviruses. J Clin Microbiol 1984;19:105-11.
84. Schaller JP, Saif LJ, Cordle CT, Candler E, Jr., Winship TR, Smith KL. Prevention of human rotavirs-induced diarrhea in gnotobiotic piglets using bovine antibody. J Infect Dis 1992;165:623-30.
85. Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K et al. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986;2:417-21.
86. Maison DO, O'Ryan ML, Pickering LK, Chiba S, Nakarta S, Raj P et al. Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol 1992;30:1056-61.
87. O'Ryan ML, Maison DO, Estes MK, Pickering LK. Anli-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis 1994;169:504-10.
88. O'Ryan ML, Maison DO, Estes MK, Pickering LK. Acquisition of serum isotype-specific and G type-specific antirotavirus antibodies among children in day care centers. Pediatr Infect Dis J 1994;13:890-5.
89. Valazquez FR, Calva JJ, Guerrero ML, Mass D, Glass RI, Pickering LK, Ruiz-Palacios CM. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J 1993;12:54-61.
90. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 1983;309:12-6.
91. Maison DO. Protective immunity against group A rotavirus infection and illness in infants. Arch Virol 1996;12(Suppl):129-39.
92. Valazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
93. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104-7.
94. Ruggeri FM, Johansen K, Basile G, Kraehenbuhl JP, Svensson L. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol 1998;72:2708-14.
95. Franco MA, Prieto I, Labbe M, Poncet D, Borras-Cuesta F, Cohen J. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J Gen Virol 1993;74:2579-86.
96. Heath RR, Stagg S, Xu FS, McCrae MA. Mapping of the target antigens of the rotavirus-specific cytotoxic T cell response. J Gen Virol 1997;78:1065-75.
97. Offit PA, Boyle DB, Both GW, Hill NL, Svoboda YM, Cunningham SL et al. Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. Virology 1991;184:563-8.
98. Clark HF, Offit PA, Ellis RW, Krah D, Shaw AR, Eiden JJ et al. WC3 reassortant vaccines in children. Arch Virol 1996;12(Suppl):187-98.
99. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Arch Virol 1996;12(Suppl):163-75.
100. Vesikari T. Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status. Arch Virol 1996;12(Suppl):177-86.
101. Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 1996;174(Suppl):S73-80.
102. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 1996;174(Suppl):S65-S72.
103. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997;350:1205-9.
104. Perez-Schael I, Guntinas MJ, Ferez M, Pagone V, Rojas AM, Gonzalez R et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997;337:1181-7.
105. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccine in US children. JAMA 1995;273:1191-6.
106. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the national multicenter trial. Pediatries 1996;97:7-13.
107. Santosham M, Moulton LH, Reid R, Croll J, Weatherbolt R, Ward R et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in native American populations. J Pediatr 1997;131:632-8.
108. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 1985;53:949-54.
109. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 1986;24:822-6.
110. Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype l, 2, 3, or 4 specificity. J Med Virol 1997;51:319-25.
111. Hoshino Y, Kapikian AZ, Chanock RM. Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro. J Virol 1994;68:7598-602.
112. Bernstein DI, Smith VE, Sherwood JR, Schiff CM, Sander DS, Defeudis D et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine 1998;16:381-7.
113. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207-22
114. Rugged FM, Greenberg HB. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 1991;65:2211-9.
115. Bachmann MF, Zinkemagel RM. The influence of virus structure on antibody responses and virus serotype formation. Immunol Today 1996;17:553-8.